{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00684",
      "entity_text" : "growth factor receptors",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0417" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "The limited efficacy of molecular therapies targeting EGFR in glioblastomas suggests that the therapeutic efficacy of EGFR inhibition may be circumvented through cross coupled signaling from other growth factor receptors that are mutated, amplified or overexpressed in these tumors, such as platelet derived growth factor receptor, alpha polypeptide (PDGFRA), ERBB2 and MET.",
  "reading_complete" : "2020-08-03T14:06:12Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T14:05:07Z",
  "trigger" : "overexpressed",
  "evidence" : [ "growth factor receptors that are mutated, amplified or overexpressed" ],
  "pmc_id" : "4199416",
  "score" : 0
}